• Published in Journal of Neurology (2020)

  • Collaborator: Ipsen

  • Authors: Comella C, Ferreira JJ, Pain E, Azoulai M, Om S.

Botulinum neurotoxin type A (BoNT-A) is an effective pharmacological treatment for the management of cervical dystonia (CD) that requires repeated administration at variable intervals. We explored patient perceptions of the impact of CD and the waning of BoNT-A therapeutic effects.